|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
COLES RALLY/REACTION DAY
Trading: HOLD @ $0.2
Signal Strength: MEDIUM
Volatility indicators highlight potential moves of a stock which can either move sharply in the updwards or downwards direction. This indicator allows stocks to be compared on a level playing field to highlight high and low volatility. Normally, falling markets are more likely to be volatile than a rising markets due to the emotion that gets tied to trading. Use volatility indicators in conjunction with other indicators to reduce exposure to false moves.
Roger Cole devised a method to use rally and reaction days. Cole disregarded inside and outside days to find three rally days in a row or three reactions in a row. This is like three soldiers or three crows in candlestick pattern analysis, except Cole allowed for inside or outside days to intervene. Three soldiers and three crows, while rare, are extremely reliable. So Cole gave us some relief from a strict definition, but traded off increased frequency at the expense of reliability. Cole also used moving average crossovers to augment the two-day (rally, reaction, inside, outside day) results.
Calculation: Coles Reaction Day:
1) Rally Day: High > High yesterday & Low > Low yesterday;
2) Reaction Day: High > High yesterday & Low < Low yesterday
PROFILE: Cogstate (CGS.AX)
Stock Exchange: ASX
Ticker Codes: | CGS.AX | ASX:CGS |
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain injury applications primarily in Australia, the United States, and Europe. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of disease and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations. As of June 30, 2017, it had participated in approximately 1,200 academic research studies in approximately 70 indications. The Healthcare segment provides Cognigram, a system that enables regular and standardized assessment of patients to detect cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.
|MOY Millennium Minerals||0.13||13.6||1,861,319||0||NEUTRAL|
|ONE Oneview Healthcare||0.29||11.8||184,305||0||NEUTRAL|
|SLR Silver Lake Resources||1.45||8.2||9,252,383||0||NEUTRAL|
|RSG Resolute Mining||1.74||7.1||9,161,059||0||NEUTRAL|
|PRU Perseus Mining||0.71||6.8||12,414,565||0||NEUTRAL|
|AEF Australian Ethical Investments||2.03||6.8||76,257||0||NEUTRAL|
|MLX Metals X||0.25||6.4||2,769,031||0||NEUTRAL|
|AQG Alacer Gold Corp||5.42||6.3||936,317||0||NEUTRAL|
|NST Northern Star Resources||13.47||6||4,840,454||0||NEUTRAL|
|OMH OM Holdings||0.86||5.5||28,581||0||NEUTRAL|